Kansas City Regional Hemophilia Center is a clinical research site located in Kansas City, Missouri, United States 64108.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Kansas City Regional Hemophilia Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hemophilia A With Inhibitor, Hemophilia B With Inhibitor.
Sponsors: American Thrombosis and Hemostasis Network.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kansas City Regional Hemophilia Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kansas City Regional Hemophilia Center has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia A With Inhibitor, Hemophilia B With Inhibitor.
Kansas City Regional Hemophilia Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.